AU5948286A - Anthranilic acid derivatives - Google Patents
Anthranilic acid derivativesInfo
- Publication number
- AU5948286A AU5948286A AU59482/86A AU5948286A AU5948286A AU 5948286 A AU5948286 A AU 5948286A AU 59482/86 A AU59482/86 A AU 59482/86A AU 5948286 A AU5948286 A AU 5948286A AU 5948286 A AU5948286 A AU 5948286A
- Authority
- AU
- Australia
- Prior art keywords
- acid derivatives
- anthranilic acid
- anthranilic
- derivatives
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical class NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3523705 | 1985-07-03 | ||
DE19853523705 DE3523705A1 (en) | 1985-07-03 | 1985-07-03 | MEDICINAL PRODUCTS AND THE USE THEREOF |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5948286A true AU5948286A (en) | 1987-01-08 |
Family
ID=6274794
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU59482/86A Abandoned AU5948286A (en) | 1985-07-03 | 1986-07-02 | Anthranilic acid derivatives |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0216028A2 (en) |
JP (1) | JPS6210057A (en) |
AU (1) | AU5948286A (en) |
DD (1) | DD248056A5 (en) |
DE (1) | DE3523705A1 (en) |
DK (1) | DK314686A (en) |
GR (1) | GR861712B (en) |
HU (1) | HUT44483A (en) |
PT (1) | PT82901B (en) |
ZA (1) | ZA864915B (en) |
ZM (1) | ZM4886A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5397798A (en) * | 1990-12-18 | 1995-03-14 | Eli Lilly And Company | Benzamide and sulfonamide hypoglycemic agents |
CN106660961A (en) * | 2014-08-29 | 2017-05-10 | 瑞士诺华动物保健有限公司 | Novel sulfonylaminobenzamide compounds as anthelmintics |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0420805A3 (en) * | 1989-09-26 | 1991-10-16 | Ciba-Geigy Ag | Anthelmintic compounds |
EP0420804A3 (en) * | 1989-09-26 | 1991-11-27 | Ciba-Geigy Ag | Anthelmintic compounds |
GB9511694D0 (en) * | 1995-06-09 | 1995-08-02 | Fujisawa Pharmaceutical Co | Benzamide derivatives |
DE19830431A1 (en) * | 1998-07-08 | 2000-01-13 | Hoechst Marion Roussel De Gmbh | Sulfonylamino-carboxylic acid N-arylamides as guanylate cyclase activators |
AU2001288518A1 (en) * | 2000-08-30 | 2002-03-13 | Primecyte, Inc. | Methods for treating tumors using sulfonyl compounds |
US7119112B2 (en) * | 2002-02-28 | 2006-10-10 | Icagen, Inc. | Sulfonamides as potassium channel blockers |
WO2005085188A2 (en) * | 2004-03-02 | 2005-09-15 | Compass Pharmaceuticals Llc | Compounds and methods for anti-tumor therapy |
US7312248B2 (en) * | 2004-09-23 | 2007-12-25 | Schering-Plough Animal Health Corporation | Control of parasites in animals by the use of novel trifluoromethanesulfonanilide oxime ether derivatives |
TW200637539A (en) * | 2005-01-20 | 2006-11-01 | Shionogi & Co | CTGF inhibitors |
CA2612976C (en) | 2005-06-21 | 2012-04-10 | Mitsui Chemicals, Inc. | Amide derivative and insecticide containing the same |
EP3802514B1 (en) | 2018-06-01 | 2022-08-03 | Promega Corporation | Inhibitors of oplophorus luciferase-derived bioluminescent complexes |
-
1985
- 1985-07-03 DE DE19853523705 patent/DE3523705A1/en not_active Withdrawn
-
1986
- 1986-06-26 EP EP86108696A patent/EP0216028A2/en not_active Withdrawn
- 1986-06-27 ZM ZM48/86A patent/ZM4886A1/en unknown
- 1986-07-01 GR GR861712A patent/GR861712B/en unknown
- 1986-07-01 HU HU862743A patent/HUT44483A/en unknown
- 1986-07-01 DD DD86292009A patent/DD248056A5/en unknown
- 1986-07-02 DK DK314686A patent/DK314686A/en not_active Application Discontinuation
- 1986-07-02 JP JP61154281A patent/JPS6210057A/en active Pending
- 1986-07-02 AU AU59482/86A patent/AU5948286A/en not_active Abandoned
- 1986-07-02 PT PT82901A patent/PT82901B/en not_active IP Right Cessation
- 1986-07-02 ZA ZA864915A patent/ZA864915B/en unknown
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5397798A (en) * | 1990-12-18 | 1995-03-14 | Eli Lilly And Company | Benzamide and sulfonamide hypoglycemic agents |
CN106660961A (en) * | 2014-08-29 | 2017-05-10 | 瑞士诺华动物保健有限公司 | Novel sulfonylaminobenzamide compounds as anthelmintics |
CN106660961B (en) * | 2014-08-29 | 2020-05-05 | 瑞士伊兰科动物保健有限公司 | Sulfonylaminobenzamide compounds as anthelmintics |
Also Published As
Publication number | Publication date |
---|---|
ZA864915B (en) | 1987-02-25 |
PT82901A (en) | 1986-08-01 |
PT82901B (en) | 1989-01-30 |
ZM4886A1 (en) | 1987-03-27 |
JPS6210057A (en) | 1987-01-19 |
DK314686A (en) | 1987-01-04 |
DD248056A5 (en) | 1987-07-29 |
EP0216028A2 (en) | 1987-04-01 |
GR861712B (en) | 1986-10-31 |
DE3523705A1 (en) | 1987-01-08 |
HUT44483A (en) | 1988-03-28 |
DK314686D0 (en) | 1986-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU572402B2 (en) | 25-avermectin derivatives | |
GB8614616D0 (en) | Thiazolidinecarboxylic acid derivatives | |
AU8292687A (en) | Thiol-carboxylic acid derivatives | |
AU8297787A (en) | 1h-imadazole-5-carboxylic acid derivatives | |
AU1415188A (en) | New ribofuranuronic acid derivatives | |
AU4282985A (en) | Quinolinecarboxylic acid derivatives | |
AU587108B2 (en) | Imidazolecarboxylic acid derivatives | |
AU576685B2 (en) | Chromoglycic acid derivatives | |
AU5948286A (en) | Anthranilic acid derivatives | |
AU6169186A (en) | Amino acid derivatives | |
AU583909B2 (en) | Substituted 2,3,4,9-Tetrahydro-1H-Carbazole-1-Acetic acid derivatives | |
AU5638686A (en) | Cyclohexylamidazole derivatives | |
AU5088485A (en) | 1-phenylimidazole-5-carboxylic acid derivatives | |
AU6603586A (en) | Imidazopyridazinealkenoic acid amides | |
AU5349386A (en) | Barbituric acid derivatives | |
AU562773B2 (en) | Tetrahydroimidazoquinazolinone derivatives | |
AU5555586A (en) | Acetic acid derivatives containing phosphorus | |
AU5504286A (en) | Cyanoalkanimidamidophenylpyridazinone derivatives | |
AU5511986A (en) | 2-arylbenzothiazine derivatives | |
AU8314987A (en) | 1-methyl-1h-imidazole-5-carboxylic acid derivatives | |
GB8509086D0 (en) | Dihydronicotinic acid derivatives | |
AU5899386A (en) | 1,4-dihydro-nicotinic acid derivatives | |
AU561320B2 (en) | Clycoside derivatives | |
AU5984386A (en) | 3-chloro-3-cephem-4-carboxylic acid derivatives | |
AU577712B2 (en) | Quinolonecarboxylic acid derivatives |